- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Global advisory board in Madrid with a UK HCP was ruled not genuine. Panel found promotion of an investigational RSV vaccine and…
Complaint alleged Google searches allowed public access to Bayer “advertisements” for medicines. Panel found documents were non-promotional or appropriately gated for HCPs.…
Ex-contractor alleged GSK hospital reps duplicated/falsified CRM call records and management knew. Referee said call frequency aspect was in scope, but Panel…
Two Jazz-funded promotional/educational HCP videos for Epidyolex omitted key SPC liver contraindication and management guidance for concomitant valproate use. PMCPA found misleading…
A clinician complained that AstraZeneca’s public corporate medicines list showed incorrect/missing black triangle symbols and omitted Imjudo. The Panel found a breach…
A GP challenged a Teva-supported insert distributed with Guidelines in Practice. The Panel found it was effectively a paid promotional insert for…
An anonymous GSK employee challenged a diabetes service partnership with a primary healthcare service company. A voicemail and contract implied funding was…
A GP challenged Pfizer’s Toviaz ads comparing fesoterodine 8mg with tolterodine ER. The PMCPA found the comparative claims misleading and unsubstantiated, and…
A nurse alleged she was told Ferinject was safe and could be given as 1,000mg in 15 minutes. The Panel found insufficient…
A GP complained about large promotional emails sent on Sandoz’s behalf. The Panel found the email was promotional but could not determine…
A health professional complained about an unsolicited email advertising a Gilead fellowship programme. The Panel found the email was non-promotional and ruled…
Roche’s Bondronat leavepiece was ruled misleading for indirect cross-trial graphs, exaggerated “renal safety reassurance” claims, and unclear interim poster data. Multiple Clause…
A Lipitor journal ad cited economic modelling (“37%” vs “82%”) on cholesterol target attainment. PMCPA found the bold percentages misleading and not…
Anonymous complaint alleged inappropriate entertainment/hospitality, biased sponsorship of delegates, and suspected off-label selling of Pergoveris at a fertility nurse meeting. PMCPA ruled…
A pharmacist said Sanofi-Aventis didn’t fulfil a reply-paid card request for Acomplia clinical papers and promotional items. Panel and Appeal Board found…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.